| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/09/2009 | WO2009043452A1 Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agent |
| 04/09/2009 | WO2009043451A2 Use of chorionic gonadotropin-beta (109-145) as a therapeutic agent |
| 04/09/2009 | WO2009043450A2 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 04/09/2009 | WO2009043449A2 Use of a peptide as a therapeutic agent |
| 04/09/2009 | WO2009043448A2 Neuromedin u-25 and neuromedin s as therapeutic agents |
| 04/09/2009 | WO2009043447A2 Use of a peptide as a therapeutic agent |
| 04/09/2009 | WO2009043441A1 D-ala-gln-octadecyl ester as a therapeutic agent |
| 04/09/2009 | WO2009043440A2 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 04/09/2009 | WO2009043439A2 Use of retrocyclin- 1 as a therapeutic agent for the treatment of hcmv infections |
| 04/09/2009 | WO2009043437A2 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 04/09/2009 | WO2009043436A2 Use of af12198 as a therapeutic agent |
| 04/09/2009 | WO2009043277A1 Skin care composition containing hsa fusion protein, method for preparation and use thereof |
| 04/09/2009 | WO2009043171A1 Method of regulating the th17 pathway and its associated metabolic impact |
| 04/09/2009 | WO2009043128A1 Use of protease inhibitors isolated from bauhinia sp. for the treatment of microbial infections and pharmaceutical composition |
| 04/09/2009 | WO2009043114A1 Arsenoxide compound and method of use |
| 04/09/2009 | WO2009043103A1 Therapeutic antibody purification method and method of use |
| 04/09/2009 | WO2009043083A1 Method and composition for modulating androgen receptor activity |
| 04/09/2009 | WO2009023416A3 Cosmetic methods and compositions for repairing human skin |
| 04/09/2009 | WO2009022067A8 Medicament for treating parkinson's disease |
| 04/09/2009 | WO2009019433A3 Fertilisation protein |
| 04/09/2009 | WO2009016384A3 Gsk-3 inhibitors |
| 04/09/2009 | WO2009015283A3 Bhc80 - histone complexes and uses thereof |
| 04/09/2009 | WO2009012785A3 Complexes of an emulgator and a fatty acid |
| 04/09/2009 | WO2009012784A3 Methods for preparing cytotoxic complexes of emulsifier and fatty acid |
| 04/09/2009 | WO2009010287A3 Specific therapy and medicament using integrin ligands for treating cancer |
| 04/09/2009 | WO2009009441A3 Self-assembling complex for targeting chemical agents to cells |
| 04/09/2009 | WO2009007719A3 Detection of micro-organisms based on their nad-dependent dna ligase activity |
| 04/09/2009 | WO2009004094A3 Compounds and methods for the treatment of renal disease |
| 04/09/2009 | WO2008156645A3 Pharmaceutical compositions and uses |
| 04/09/2009 | WO2008151841A3 Treatment for alzheimer' s disease |
| 04/09/2009 | WO2008144754A3 Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases |
| 04/09/2009 | WO2008144351A3 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations |
| 04/09/2009 | WO2008107533A3 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology |
| 04/09/2009 | WO2008105826A3 Compositions compromising lysostaphin variants and methods of using the same |
| 04/09/2009 | WO2008088902A8 Attenuation of the adaptive immune response |
| 04/09/2009 | WO2008084115A3 Lactococcus promoters and uses thereof |
| 04/09/2009 | WO2008080167A3 Fluidized spray drying |
| 04/09/2009 | WO2008070666A3 Compositions and methods to treat cancer with cpg rich dna and cupredoxins |
| 04/09/2009 | WO2008070303A3 Therapeutics to inhibit mll-menin interaction for treating leukemia |
| 04/09/2009 | WO2008063808A3 Encapsulated peptide amphiphile nanostructures |
| 04/09/2009 | WO2008055145A3 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 04/09/2009 | WO2008052185A3 Materials and methods for the treatment of celiac disease |
| 04/09/2009 | WO2008043107A3 Use of tight junction antagonists to treat inflammatory bowel disease |
| 04/09/2009 | WO2008037720A3 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure |
| 04/09/2009 | WO2008036682A3 Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| 04/09/2009 | WO2008030539A3 Methods and compositions based on diphtheria toxin-interleukin-3 conjugates |
| 04/09/2009 | WO2008026224A3 Novel nanoparticles of apotransferrin / transferrin, pharmaceutical composition containing them and processes for their preparation |
| 04/09/2009 | WO2008024509A3 Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 04/09/2009 | WO2008019062A3 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/09/2009 | WO2008014054A3 Bmp-7 variant compositions, methods and uses |
| 04/09/2009 | WO2008012796A3 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
| 04/09/2009 | WO2008011624A3 Crystal structure of a receptor-ligand complex and methods of use |
| 04/09/2009 | WO2008006019A3 Growth hormone releasing hormone treatment to decrease cholesterol levels |
| 04/09/2009 | WO2007146232A3 Compositions and methods for repair of tissues |
| 04/09/2009 | WO2007121459A3 Detection of steroid receptors on circulating carcinoma cells and treatment |
| 04/09/2009 | WO2007046103A3 System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof |
| 04/09/2009 | WO2007038623A3 Oral formulation for enteric disorders and/or rehydration |
| 04/09/2009 | WO2007035363A3 Compositions and methods for the augmentation and repair of defects in tissue |
| 04/09/2009 | WO2007000768A3 Gliomedin, fragments thereof and methods of using same |
| 04/09/2009 | WO2006127048A3 NOVEL pH DEPENDENT ADHESIVE PEPTIDES |
| 04/09/2009 | WO2006126981A3 Compositions and methods for mucosal vaccination |
| 04/09/2009 | WO2006105109A3 Methods for generating new hair follicles, treating baldness, and hair removal |
| 04/09/2009 | WO2006102087A3 Hcv protease substrates |
| 04/09/2009 | WO2006089218A3 Methods and compositions for modulating angiogenesis |
| 04/09/2009 | WO2006085979A3 Soluble forms of hendra and nipah virus g glycoprotein |
| 04/09/2009 | WO2006076024A3 A method for targeting synapse with acetylcholinesterase |
| 04/09/2009 | WO2006069001A3 Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands |
| 04/09/2009 | WO2006057633A3 Method for designing polypeptides for the nanofabrication of thin films, coatings and microcapsules by electrostatic layer-by-layer self assembly. |
| 04/09/2009 | WO2006047744A3 Compositions of lactoferrin related peptides and uses thereof |
| 04/09/2009 | WO2006045076A3 Virus scaffold for self-assembled, flexible and light lithium battery |
| 04/09/2009 | WO2006044333A3 Methods and materials for the inhibition of transplant rejection |
| 04/09/2009 | WO2006036860A3 Kallikrein inhibitors and uses thereof |
| 04/09/2009 | WO2006028684A3 Phytases, nucleic acids encoding them and methods of making and using them |
| 04/09/2009 | WO2006026325A3 Implantable tissue compositions and method |
| 04/09/2009 | WO2006021874A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 04/09/2009 | WO2005123099A3 Methods and compositions for accelerating alcohol metabolism |
| 04/09/2009 | WO2005118876A3 Egfr mutations |
| 04/09/2009 | WO2005112998A3 Compositions and methods for preventing erythropoietin-associated hypertension |
| 04/09/2009 | WO2005112979A3 Methods of preventing and treating alimentary mucositis |
| 04/09/2009 | WO2005110059A3 Treatment of severe community-acquired pneumonia by admistration of tissue factor pathway inhibitor (tfpi) |
| 04/09/2009 | WO2005097826A3 Prokineticin 2beta peptide and its use |
| 04/09/2009 | WO2005086775A3 Lumen-exposed molecules and methods for targeted delivery |
| 04/09/2009 | WO2005074415A3 Antimicrobial, synthetic, fibrous, and tubular medical devices |
| 04/09/2009 | WO2005059099A3 Human ipla2t |
| 04/09/2009 | WO2005032496A3 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/09/2009 | WO2005021712A3 Modified molecular beacons |
| 04/09/2009 | WO2005007078A3 Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars) |
| 04/09/2009 | WO2004112728A3 Methods and agents for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons |
| 04/09/2009 | WO2004110360A3 Proteoglycan degrading mutants for treatment of cns |
| 04/09/2009 | WO2004100896A3 Anti-aging nutritional supplement |
| 04/09/2009 | WO2004084811A3 Crystals and structures of epidermal growth factor receptor kinase domain |
| 04/09/2009 | WO2004083395A3 Transporters and ion channels |
| 04/09/2009 | WO2004079334A3 Biomarker detection based on aspects of ion mobility |
| 04/09/2009 | WO2004011617A8 Identification of a novel bitter taste receptor, t2r76 |
| 04/09/2009 | US20090094715 Methods of use of antibodies with reduced immunogenicity or toxicity |
| 04/09/2009 | US20090094708 Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives |
| 04/09/2009 | US20090093639 Prodrugs of carbamate inhibitors of IMPDH |
| 04/09/2009 | US20090093613 Treatment of tinnitus |
| 04/09/2009 | US20090093447 Cddo-compounds and combination therapies thereof |
| 04/09/2009 | US20090093438 RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |